Introducing neuroimmune pharmacology

Neuroimmune Pharmacology

Volumn , Issue , 2008, Pages 1-3

  Gendelman, Howard E ^a   Ikezu, Tsuneya ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Immunology; Neuroscience; Pharmacology

Indexed keywords

EID: 84900261219     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-72573-4_1     Document Type: Chapter

References (28)

1. Appel SH, Smith RG, Alexianu M, Siklos L, Engelhardt J, Colom LV, Stefani E (1995). Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis. Clin Neurosci 3:368-374.
2. Axel R (2005). Scents and sensibility: A molecular logic of olfactory perception (Nobel lecture). Angew Chem Int Ed Engl 44:6110-6127.
3. Becher B, Prat A, Antel JP (2000). Brain-immune connection: Immunoregulatory properties of CNS-resident cells. Glia 29:293-304.
4. Buck LB (2000). The molecular architecture of odor and pheromone sensing in mammals. Cell 100:611-618.
5. Carlsson A (2001). A half-century of neurotransmitter research: Impact on neurology and psychiatry (Nobel lecturey). Biosci Rep 21:691-710.
6. Christen U, von Herrath MG (2004). Initiation of autoimmunity. Curr Opin Immunol 16:759-767.
7. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000). The sympathetic nerve-an integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 52:595-638.
8. Ercolini AM, Miller SD (2005). Role of immunologic cross-reactivity in neurological diseases. Neurol Res 27:726-733.
9. Gendelman HE (2002). Neural immunity: Friend or foe. J Neurovirol 8:474-479.
10. Gendelman HE, Persidsky Y (2005). Infections of the nervous system. Lancet Neurol 4:12-13.
11. Gilman AG (1995). Nobel lecture G proteins and regulation of adenylyl cyclase. Biosci Rep 15:65-97.
12. Greengard P (2001). The neurobiology of dopamine signaling. Biosci Rep 21:247-269.
13. Hughes AL (2002). Natural selection and the diversification of vertebrate immune effectors. Immunol Rev 190:161-168.
14. Kandel ER (2001). The molecular biology of memory storage: A dialogue between genes and synapses. Science 294:1030-1038.
15. McGeer PL, McGeer EG (2004). Inflammation and the degenerative diseases of aging. Ann NY Acad Sci 1035:104-116.
16. Petranyi GG (2002). The complexity of immune and alloimmune response. Transpl Immunol 10:91-100.
17. Prusiner SB (1998). Prions. Proc Natl Acad Sci USA 95:13363-13383.
18. Prusiner SB (2001). Shattuck lecture-neurodegenerative diseases and prions. N Engl J Med 344:1516-1526.
19. Rock RB and Peterson PK (2006). Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J Neuroimm Pharm 1:117-117.
20. Rodbell M (1995). Nobel lecture signal transduction: Evolution of an idea. Biosci Rep 15:117-133.
21. Samaniego M, Becker BN, Djamali A (2006). Drug insight: Maintenance immunosuppression in kidney transplant recipients. Nat Clin Pract Nephrol 2:688-699.
22. Schwartz M (2001). Harnessing the immune system for neuroprotection: Therapeutic vaccines for acute and chronic neurodegenerative disorders. Cell Mol Neurobiol 21:617-627.
23. Schwartz M, Kipnis J (2004). A common vaccine for fighting neurodegenerative disorders: Recharging immunity for homeostasis. Trends Pharmacol Sci 25:407-412.
24. Sehgal A, Berger MS (2000). Basic concepts of immunology and neuroimmunology. Neurosurg Focus 9:e1.
25. Simard M, Nedergaard M (2004). The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129:877-896.
26. Streilein JW (1993). Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol 5:428-432.
27. Toyka KV, Gold R (2003). The pathogenesis of CIDP: Rationale for treatment with immunomodulatory agents. Neurology 60:S2-S7.
28. Trendelenburg G, Dirnagl U (2005). Neuroprotective role of astrocytes in cerebral ischemia: Focus on ischemic preconditioning. Glia 50:307-320.